Deerland Enzymes   Report issue

For profit Phase 3
Founded: Kennesaw GA United States (1990)
Status: No NME R&D (1990)

Organization Overview

First Clinical Trial
2016
NCT04083521
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Deerland Enzymes | Deerland Probiotics and Enzymes

Active Ingredients

Drugs in Phase 3 Trials (1)

preforpro (1 trial)

Drugs in Other Trials (7)

bacillus clausii (1 trial)

bacillus coagulans (1 trial)

bacillus subtilis (4 trials)

maltodextrin (2 trials)

mit411 (1 trial)

solarplast (2 trials)

whey protein (1 trial)

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial APIs: 8